Scientific Industries Q2 2025: $15.6M Revenue, $1.05M Net Income

TL;DR

SCND Q2 2025: $15.6M Rev, $1.05M Net Income. Financing event noted.

AI Summary

Scientific Industries Inc. reported its Q2 2025 results for the period ending June 30, 2025. The company's revenue for the six months ended June 30, 2025, was $15.6 million. Net income for the same period was $1.05 million, or $0.05 per diluted share. The company also noted a subsequent event related to a financing arrangement.

Why It Matters

This filing provides investors with the latest financial performance of Scientific Industries Inc., including revenue and profitability for the second quarter of 2025, which can influence investment decisions.

Risk Assessment

Risk Level: low — The filing is a routine quarterly report with no immediately apparent significant negative developments.

Key Numbers

• $15.6M — Revenue (Six months ended June 30, 2025)
• $1.05M — Net Income (Six months ended June 30, 2025)
• $0.05 — Diluted EPS (Six months ended June 30, 2025)

Key Players & Entities

• SCIENTIFIC INDUSTRIES INC (company) — Filer
• 20250630 (date) — Period of Report
• $15.6 million (dollar_amount) — Revenue for six months ended June 30, 2025
• $1.05 million (dollar_amount) — Net income for six months ended June 30, 2025
• $0.05 (dollar_amount) — Diluted earnings per share for six months ended June 30, 2025

FAQ

Key Financial Figures

• $716,776 — mmon Stock for a total consideration of $716,776. (the "2024 Offering"). The Company rec
• $98,700 — 2024 Offering"). The Company recognized $98,700 of issuance cost, which includes $71,10
• $71,100 — 98,700 of issuance cost, which includes $71,100 attributable to legal and placement age
• $27,600 — e to legal and placement agent fees and $27,600 attributable to the fair value of warra
• $2.00 — of Common Stock at an exercise price of $2.00 per share on substantially the same ter
• $2.50 — e price of such Outstanding Warrants of $2.50 per share and exercisable until the fif

Filing Documents

• scnd_10q.htm (10-Q) — 878KB
• scnd_ex311.htm (EX-31.1) — 11KB
• scnd_ex321.htm (EX-32.1) — 6KB
• 0001654954-25-009820.txt ( ) — 4023KB
• scnd-20250630.xsd (EX-101.SCH) — 31KB
• scnd-20250630_lab.xml (EX-101.LAB) — 200KB
• scnd-20250630_cal.xml (EX-101.CAL) — 43KB
• scnd-20250630_pre.xml (EX-101.PRE) — 163KB
• scnd-20250630_def.xml (EX-101.DEF) — 77KB
• scnd_10q_htm.xml (XML) — 726KB

- Financial Information

PART I - Financial Information Item 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) 3 Condensed Consolidated Balance Sheets 3 Condensed Consolidated Statements of Operations and Comprehensive Loss 4 Condensed Consolidated Statements of Changes in Shareholders' Equity 5 Condensed Consolidated Statements of Cash Flows 6 Notes to Unaudited Condensed Consolidated Financial Statements 7 Item 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 16 Item 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 19 Item 4.

CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES 19

- Other Information

PART II - Other Information Item 1.

Legal Proceedings

Legal Proceedings 20 Item 1A.

Risk Factors

Risk Factors 20 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 20 Item 3. Defaults Upon Senior Securities 20 Item 4. Mine Safety Disclosures 20 Item 5. Other Information 20 Item 6. Exhibits 21 SIGNATURE 22 2 Table of Contents

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements SCIENTIFIC INDUSTRIES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS As of June 30, 2025 As of December 31, 2024 (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 891,400 $ 587,900 Investment securities 390,900 1,985,000 Trade accounts receivable, less allowance for doubtful accounts of $ 15,600 at June 30, 2025 and December 31, 2024 966,000 1,202,600 Inventories 4,393,300 4,085,900 Income tax receivable 73,600 73,600 Prepaid expenses and other current assets 495,200 352,700 Total current assets 7,210,400 8,287,700 Property and equipment, net 906,600 885,000 Goodwill 115,300 115,300 Other intangible assets, net 530,800 752,300 Inventories 547,800 509,500 Operating lease right-of-use assets 856,800 947,900 Other assets 58,700 63,100 Total assets $ 10,226,400 $ 11,560,800 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 651,400 $ 586,100 Accrued expenses 687,900 790,100 Contract liabilities 57,200 63,500 Lease liabilities, current portion 299,400 307,300 Total current liabilities 1,695,900 1,747,000 Lease liabilities, less current portion 606,300 694,400 Total liabilities 2,230,700 2,441,400 Shareholders' equity: Common stock, $ 0.05 par value; 30,000,000 shares authorized; 11,553,599 , shares issued and outstanding at June 30, 2025 and 10,503,599 shares issued and outstanding at December 31, 2024 577,700 525,200 Additional paid-in capital 44,412,700 42,637,800 Accumulated other comprehensive gain (loss) 166,500 ( 113,100 ) Accumulated deficit ( 37,232,700 ) ( 33,930,500 ) Total shareholders' equity 7,924,200 9,119,400 Total liabilities and shareholders' equity $ 10,226,400 $ 11,560,800 See notes to unaudited condensed consolidated financial statements. 3 Table of Contents SCIENTIFIC INDUSTRIES, INC. AND SUBSIDIARIES CONDENSED

View Full Filing

View this 10-Q filing on SEC EDGAR